IL15RA and acute myeloid leukemia: For example, co-expression of IL-15/IL-15Rα and CD80 in syngeneic acute myeloid leukemia (AML) vaccines generated potent, durable anti-leukemic immunity, yielding 50% overall survival in murine models [35].